<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02220166</url>
  </required_header>
  <id_info>
    <org_study_id>GE-GA2-2010</org_study_id>
    <nct_id>NCT02220166</nct_id>
  </id_info>
  <brief_title>Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease</brief_title>
  <official_title>Phase II Study on Safety of 60 Days Administration of Triticum Monococcum in Patients With Celiac Disease on Remission in Gluten Free Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Brescia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi di Brescia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preliminary studies on safety profile of Triticum Monococcum (Tm, a variety of Ancient Wheat)
      have provided conflicting results with some in vitro and ex vivo studies consistent with non
      toxicity and other suggestive of toxicity. We recently reported results of a single
      administration of 2.5 grams of Tm in 12 Celiacs in remission on Gluten Free Diet (GFD), while
      assessing symptoms and changes of intestinal permeability. Although results of intestinal
      permeability were inconclusive Tm, but not other type of gluten, was clinically well
      tolerated.

      The aim of the present study was to assess safety of 60 days of administration of Tm (100
      grams of water biscuits per day accounting for about 6 grams of gluten from Tm) as judged on
      clinical, serological and histological parameters in Celiac Disease patients on remission
      after 1 year of GFD.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Histologic: 4 duodenal biopsies obtained and classified according to Marsh</measure>
    <time_frame>Baseline, Day 60</time_frame>
    <description>After 60 days of daily administration of Tm endoscopic biopsies were performed and reviewed by the same experienced pathologist</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical: Change in Gastrointestinal Symptom Rating Scale (GSRS)</measure>
    <time_frame>Baseline, Day 30, Day 60</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Serological: test for immunoglobulin A anti tissue transglutaminases and anti-endomysial</measure>
    <time_frame>Baseline, Day 30, Day 60</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>Triticum monococcum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60 days of daily administration of 100 grams of water biscuits of Triticum monococcum</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Triticum monococcum</intervention_name>
    <arm_group_label>Triticum monococcum</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult Celiac patients on Gluten Free Diet (GFD) for at least one year

          -  Strict adherence to GFD

          -  Negative Celiac related serology

          -  Normal duodenal Histology defined as Marsh Class 0-II

          -  Willing to participate and adhere to study protocol

          -  Sign of the informed consent

        Exclusion Criteria:

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alberto Lanzini, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Università degli Studi di Brescia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbara Zanini, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi di Brescia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AO Spedali Civili of Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>I-25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Zanini B, Petroboni B, Not T, Di Toro N, Villanacci V, Lanzarotto F, Pogna N, Ricci C, Lanzini A. Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. BMC Gastroenterol. 2013 May 24;13:92. doi: 10.1186/1471-230X-13-92.</citation>
    <PMID>23706063</PMID>
  </reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2014</study_first_submitted>
  <study_first_submitted_qc>August 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2014</study_first_posted>
  <last_update_submitted>August 18, 2014</last_update_submitted>
  <last_update_submitted_qc>August 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Brescia</investigator_affiliation>
    <investigator_full_name>Alberto Lanzini, MD PhD</investigator_full_name>
    <investigator_title>Associate Professor of Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Celiac Disease</keyword>
  <keyword>Gluten</keyword>
  <keyword>Gluten free diet</keyword>
  <keyword>Triticum monococcum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

